AstraZeneca tweaks financial reporting; Spanish competition authority investigates Pfizer contracts;

@FiercePharma: Health Canada pledges more plant inspections and more transparency. More from FiercePharmaManufacturing | Follow @FiercePharma

@EricPFierce: MS Pharma in Jordan gets $30M development loan to expand its drug manufacturing. FiercePharmaManufacturing article | Follow @EricPFierce

@CarlyHFierce: Novartis ($NVS) gets bragging rights on first U.S. biosim. But will its Neupogen copy sell? Story | Follow @CarlyHFierce

> AstraZeneca ($AZN) said it would change its financial reporting to make revenue from external ventures more visible to investors; the change won't affect its 2015 outlook, the company said. Report

> Spain's antitrust commission opened an investigation into Pfizer's ($PFE) unit there, saying its contracts and pricing may be hampering EU trade in pharmaceuticals; the U.S.-based drug giant lost a related appeal at the Spanish Supreme Court last month. Report | Report

> AbbVie ($ABBV) CEO Rick Gonzalez said a new form of Humira is "a fundamental change" in the drug's formulation and could help fight off generic erosion to the franchise when biosimilars appear. Report

> Catalyst Pharmaceuticals said the FDA had given breakthrough status to its drug Firdapse as a treatment for Congenital Myasthenic Syndromes, a rare neuromuscular disease. Release

Medical Device News

@FierceMedDev: Navidea joins forces with Norgine to market cancer imaging Dx in EU. FierceDiagnostics story | Follow @FierceMedDev

@VarunSaxena2: Now with ""s from OptiNose: Evidence that inhaled oxytocin improves social behavior among autistic patients spurs R&D. FierceDrugDelivery story | Follow @VarunSaxena2

@EmilyWFierce: ICYMI yesterday: New superbug outbreak tied to endoscope devices surfaces amid FDA scrutiny. Article | Follow @EmilyWFierce

> EndoChoice raises $57M led by Deerfield to offer a better endoscopy view. News

> Johnson & Johnson ($JNJ) ordered to hand over $5.6M in vaginal mesh trial. More

Biotech News

@FierceBiotech: EuroBiotech: Billionaires plot Stallergenes merger, Cerenis set for IPO, Big Pharma-backed Opsona eyes IPO. Report | Follow @FierceBiotech

@JohnCFierce: You know Richard Gonzalez is sweating it out when he gives an interview like this ($ABBV). More from Reuters | Follow @JohnCFierce

@DamianFierce: "In 2009, $PCYC's shares fell to a record low 57 cents. $ABBV is paying cash and stock worth $261.25 a share." WSJ story | Follow @DamianFierce

> Novartis ($NVS) wins landmark approval for a biosimilar of Amgen's Neupogen. News

> Gates Foundation bets $52M on CureVac's mRNA promise. More

> Merck ($MRK) dumps 120 Cubist researchers after its $9.5B merger. Report

And Finally... Losing as little as half an hour of shuteye on weekdays may help trigger insulin resistance and obesity, a study found. Report

Suggested Articles

Former Indivior CEO Shaun Thaxter will face six months in federal prison for his role in misleading government officials on the dangers of Suboxone.

As of Friday after local time, 36 people have died in Korea after getting flu shots provided by at least seven companies, including Sanofi.

Two prominent pneumococcal vaccines from Merck and Pfizer are running low in Europe in a possible ill omen for the coming winter: report.